Share chart ChemoCentryx, Inc.
About
ChemoCentryx, Inc., биофармацевтическая компания, работающая на клинической стадии, специализируется на разработке и коммерциализации новых лекарств от воспалительных заболеваний, аутоиммунных заболеваний и рака в Соединенных Штатах.
More detailsP/S | 12.71 |
---|---|
P/BV | 36.98 |
EV/EBITDA | 2.84 |
EBITDA | 0.0183 |
Цена ао | 51.89 |
Сайт | https://www.chemocentryx.com |
Число акций ао | 0.07123 млрд |
Выручка | 0.0825 |
P/E | 16 |
Див.доход ао | 0 |
Change price per day: | 0% (51.99) |
---|---|
Change price per week: | 0% (51.99) |
Change price per month: | 0% (51.99) |
Change price per 3 month: | 0% (51.99) |
Change price per half year: | 0% (51.99) |
Change price per year: | +0.1927% (51.89) |
Change price per 3 year: | +34.65% (38.61) |
Change price per 5 year: | +302.71% (12.91) |
Change price per year to date: | 0% (51.99) |
All parameters ⇨
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Transaction date | Date of disclosure | Insider | Type | Price | Volume | Quantity | Share before, % | Share after, % | Document |
---|---|---|---|---|---|---|---|---|---|
04.08.2022 | 08.08.2022 | Cappel Markus J. Chief Bus. Officer & Treasurer |
Sale | 50.22 | 379 864 | 7564 | 0 | -0.01 | link |
04.08.2022 | 08.08.2022 | Tyree James L Director |
Sale | 50.22 | 502 200 | 10000 | 0 | -0.01 | link |
04.08.2022 | 08.08.2022 | KANAYA SUSAN M EVP, CFO and Sec. |
Sale | 50.17 | 2 322 770 | 46298 | 0 | -0.07 | link |
04.08.2022 | 08.08.2022 | KANAYA SUSAN M EVP, CFO and Sec. |
Purchase | 6.5 | 300 937 | 46298 | 0 | 0.07 | link |
04.08.2022 | 08.08.2022 | Schall Thomas J. President and CEO |
Sale | 50.24 | 6 531 200 | 130000 | 0 | -0.19 | link |
20.05.2022 | 24.05.2022 | Jain Rita EVP, Chief Medical Officer |
Purchase | 21.41 | 165 414 | 7726 | 0 | 0.01 | link |
20.05.2022 | 24.05.2022 | MCKINNELL HENRY A Director |
Purchase | 21.41 | 165 414 | 7726 | 0 | 0.01 | link |
27.03.2022 | 29.03.2022 | Jain Rita EVP, Chief Medical Officer |
Purchase | 25.71 | 135 003 | 5251 | 0 | 0.01 | link |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Dr. Thomas J. Schall Ph.D. | Founder, Pres, CEO & Chairman | 1.21M | 1959 (65 years) |
Ms. Susan M. Kanaya | Exec. VP, Chief Financial & Admin. Officer, Sec. and Director | 845.04k | 1963 (61 year) |
Mr. Tausif Butt | Exec. VP & COO | 1.01M | 1966 (58 years) |
Ms. Kari E. Leetch | Sr. VP of HR | N/A | |
Dr. Sangita Ghosh Ph.D. | Sr. VP of Technical Operations | N/A | |
Dr. Rita I. Jain M.D. | Exec. VP, Chief Medical Officer & Exec. Employee Director | 670.7k | 1963 (61 year) |
Dr. Markus J. Cappel Ph.D. | Chief Bus. Officer & Treasurer | 643.58k | 1961 (63 years) |
Ms. Yi Ching Yau | Sr. VP of Fin. & Principal Accounting Officer | N/A | 1976 (48 years) |
Mr. William S. Slattery | VP of Investor Relations & Corp. Communications | N/A | |
Address: United States, San Carlos, CA , 835 Industrial Avenue - open in Google maps, open in Yandex maps
Website: https://www.chemocentryx.com
Website: https://www.chemocentryx.com